Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024

SELL
$0.36 - $0.61 $90 - $152
-250 Reduced 1.42%
17,338 $6,000
Q1 2024

Apr 22, 2024

SELL
$0.4 - $0.91 $40 - $91
-100 Reduced 0.57%
17,588 $9,000
Q4 2023

Feb 08, 2024

SELL
$0.71 - $0.97 $355 - $485
-500 Reduced 2.75%
17,688 $16,000
Q3 2023

Nov 02, 2023

BUY
$0.96 - $2.01 $4,396 - $9,205
4,580 Added 33.66%
18,188 $17,000
Q2 2023

Aug 04, 2023

SELL
$1.59 - $2.29 $477 - $687
-300 Reduced 2.16%
13,608 $23,000
Q4 2022

Feb 07, 2023

BUY
$2.06 - $3.47 $28,650 - $48,260
13,908 New
13,908 $30,000
Q3 2022

Oct 24, 2022

BUY
$2.6 - $5.12 $36,160 - $71,208
13,908 New
13,908 $40,000
Q1 2022

Apr 22, 2022

SELL
$3.28 - $7.12 $33,721 - $73,200
-10,281 Closed
0 $0
Q4 2021

Feb 08, 2022

BUY
$6.55 - $13.25 $67,340 - $136,223
10,281 New
10,281 $68,000

Others Institutions Holding ME

About 23andMe Holding Co.


  • Ticker ME
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 259,768,000
  • Market Cap $992M
  • Description
  • 23andMe Holding Co. operates as a consumer genetics testing company. It operates through two segments, Consumer & Research Services and Therapeutics. The Consumer & Research Services segment provides a suite of genetic reports, including information on customers' genetic ancestral origins, personal genetic health risks, and chances of pa...
More about ME
Track This Portfolio

Track Main Street Financial Solutions, LLC Portfolio

Follow Main Street Financial Solutions, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Main Street Financial Solutions, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Main Street Financial Solutions, LLC with notifications on news.